In 2023, the Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage in France stood at an actual value of 91%. The forecast for 2024 predicts an increase to 92%, followed by a steady upward trajectory with 93% in 2025 and 94% in 2026 and 2027. By 2028, coverage is expected to reach 95%. The year-on-year variations indicate a modest growth trend, with increases of approximately 1% each year. The Compound Annual Growth Rate (CAGR) over the five-year forecast period from 2024 to 2028 is about 0.83%.
Future trends to watch for:
- Changes in governmental health policies or public health campaigns that could influence vaccination rates.
- Potential social or economic factors affecting public health priorities and accessibility of vaccines.
- Advancements in vaccine technology or alternatives which could impact coverage rates.
